Adelene Q Perkins Insider Trading
Get free email notifications about insider trading for Adelene Q Perkins.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adelene Q Perkins. Adelene Q Perkins is a Director in BRUKER CORP ($BRKR) and a CFO and Treasurer in INFINITY PHARMACEUTICALS, INC. ($INFI) and a CFO,Treasurer and Secretary in INFINITY PHARMACEUTICALS, INC. ($INFI) and an Chief Executive Officer in INFINITY PHARMACEUTICALS, INC. ($INFI) and a EVP and Chief Business Officer in INFINITY PHARMACEUTICALS, INC. ($INFI) and a Pres & Chief Business Officer in INFINITY PHARMACEUTICALS, INC. ($INFI) and an Pres & Chief Executive Officer in INFINITY PHARMACEUTICALS, INC. ($INFI) and a President & CEO in INFINITY PHARMACEUTICALS, INC. ($INFI) and a See Remarks in INFINITY PHARMACEUTICALS, INC. ($INFI).
Address: C/O INFINITY PHARMACEUTICALS, INC. 780 MEMORIAL DRIVE CAMBRIDGE 02139 MA
Companies in which Adelene Q Perkins is an Insider
BRUKER CORP
Trading Symbol: BRKRIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Adelene Q Perkins: Director
Holdings: 15,138 shares
Current Value: $364,826
Latest Transaction: Jan 07 2021
$BRKR Market Capitalization: $3.96B
$BRKR Previous Close: $24.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INFINITY PHARMACEUTICALS, INC.
Trading Symbol: INFIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adelene Q Perkins: President & CEO, See Remarks, Pres & Chief Executive Officer, Pres & Chief Business Officer, EVP and Chief Business Officer, CFO and Treasurer, CFO,Treasurer and Secretary
Holdings: 793,190 shares
Current Value: $1,863,997
Latest Transaction: Dec 23 2020
$INFI Market Capitalization: $115.87M
$INFI Previous Close: $2.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Adelene Q Perkins
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 07 2021 | BRKR | BRUKER CORP | Perkins Adelene Q | Director | Grant | A | 0.00 | 2,302 | 0 | 15,138 | 12.8 K to 15.1 K (+17.93 %) |
Dec 23 2020 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Option Exercise | A | 2.14 | 485,000 | 1,037,900 | 485,000 | |
Jan 13 2020 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Option Exercise | A | 1.25 | 606,250 | 757,813 | 606,250 | |
Jan 13 2020 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Grant | A | 0.00 | 155,134 | 0 | 793,190 | 638.1 K to 793.2 K (+24.31 %) |
Jan 07 2020 | BRKR | BRUKER CORP | Perkins Adelene Q | Director | Grant | A | 0.00 | 2,472 | 0 | 12,836 | 10.4 K to 12.8 K (+23.85 %) |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Option Exercise | A | 1.24 | 242,000 | 300,080 | 242,000 | |
Jan 10 2019 | BRKR | BRUKER CORP | Perkins Adelene Q | Director | Grant | A | 0.00 | 4,134 | 0 | 10,364 | 6.2 K to 10.4 K (+66.36 %) |